Both BA1105 and BA1301 Being Granted Orphan Drug Designations for Treatment of Pancreatic Cancer by the FDA

Finance Lease Agreement

List of directors and their roles and functions

Resignation of Non-Executive Director

List of Directors and their Roles and Functions

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

1st Patient Enrolled in Phase 3 Study of Boan’s Nivolumab

Boan Biotech (6955.HK) announced today that the first patient in Phase III clinical trial of its Nivolumab Injection (BA1104) in China has been enrolled. BA1104 is the first biosimilar to Opdivo® to u...

Voluntary Announcement First Patient Enrolled in Phase III Clinical Trial of Nivolumab Injection (BA1104) in China

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023